A Controlled Comparative Clinical Trial to Evaluate the Efficacy of Jambwadi Kashaya over Vasadi Kashaya in the Management of Raktapradara(Dysfunctional Uterine Bleeding)
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Effect of Trial drug on improvement of classical symptoms of Raktapradara (Dysfunctional Uterine Bleeding)
研究概览
简要总结
Raktapradara has been mentioned one among Rakta pradoshaja vikara. It is mentioned in ayurveda that vitiated vata withholding rakta increases in their amount and reaches rajavaha srotas and increases raja. The excessive flow of raja from yoni is known as Raktapradara. Clinical features of Raktapradara includes atiarthava pravrutti, deergakala arthava pravrutti associated with savedana arthava pravrutti and anga marda.
Raktapradara can be corelated with Dysfunctional Uterine Bleeding explained in modern science. DUB is a state of abnormal uterine bleeding without any clinically detectable organic, systemic and iatrogenic cause(PID, Pregnancy etc excluded).
Objectives of the study is to evaluate the effect of Jambwadi Kashaya in the management of Raktapradara (DUB). This is the randomized comparative clinical study. Total 40 patients of Raktapradara are selected and randomly devided into 2 groups. Group A given Jambwadi Kashaya and Group B given Vasadi Kashaya. The subjective and objective parameters are selected for assessment. Total study duration is 3 Menstrual Cycles and includes 3 visits. After study data will be collected from case report form and statistically analysed by using appropriate parametric and non parametric tests and result will be obtained. On the basis of result conclusion will be drawn.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 16.00 Year(s) 至 40.00 Year(s)（—）
- 性别
- Female
入选标准
- •1.Patients of age group
- •40 years 2.Patients with excessive and prolonged bleeding p/v during menstruation 3.Patient willing to sign Consent form.
排除标准
- •1.Hb% below 8gms 2.Patient using Intra uterine contraceptive devices 3.Known cases of Hypertension, Diabetes mellitus, Malignancy, Tuberculosis or any uncontrolled severe systematic disorders and metabolic disorders 4.Known cases of Coagulation disorders 5.Known cases of any pelvic pathology (e.g.Uterine fibroid, Pelvic inflammatory disease) 6.Any other illness reseacher feels that interfere the inyervention of the study.
结局指标
主要结局
Effect of Trial drug on improvement of classical symptoms of Raktapradara (Dysfunctional Uterine Bleeding)
时间窗: 5 Days - Starting fron 5th day of menstruation for 5 days X 2 consecutive cycles | Follow up - 10th of Menstruation
次要结局
- Safety of the Trial drug and adverse drug reaction and aggravation in symptoms of Raktapradara(Dysfunctional Uterine Bleeding)(5 Days - Starting fron 5th day of menstruation for 5 days X 2 consecutive cycles)
研究者
Dr Soumya Benachanamardi
SDMTs Ayurvedic College and Hospital Terdal